New insights on strategies to treat infants with seizures

New recommendations offer insights on strategies for treating infants with seizures. In an Epilepsia report, child neurologists who are members of the International League Against Epilepsy note that intervening at the time of a febrile seizure does not alter the risk for subsequent epilepsy, and there is no evidence to support the use of antiepileptic drugs for simple febrile seizures. However, recurrent seizures warrant an urgent assessment, and a variety of antiepileptic drugs may benefit these patients. Unfortunately, there is no high level evidence to support the use of any one particular drug among those that are currently available for use in infants with seizures.

"Whilst this report provided some recommendations, for the most part it identified the significant lack of evidence to support our standard operating procedures. Initially intended as a guideline, it was re-termed a recommendation based on this lack of evidence-based data," said Professor Jo Wilmshurst, lead author. "For the areas of expert opinion, readers could elect to adapt this data to ensure the best care possible for their patients, whilst we await further studies to consolidate a higher evidence base to enable a definitive comment on common practice."

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Expanding access to GLP-1 weight-loss drugs could save thousands of lives